Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ambrx Biopharma Inc ADR (NY: AMAM ) 10.13 UNCHANGED Last Price Updated: 7:00 PM EDT, Mar 16, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 10.13 Bid (Size) 10.66 (3) Ask (Size) 11.24 (1) Prev. Close 10.13 Today's Range 10.13 - 10.13 52wk Range N/A - N/A Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Dividend Stocks That Are Too Good to Ignore: Q1 Edition February 26, 2024 Here are the three dividend stocks that will never disappoint you. Buy them while they trade at a discount. Via InvestorPlace 3 Stocks to Buy That Are Up 200% or More in 2024 February 23, 2024 Each of these stocks up 200% in 2024 offer unique upside opportunities for investors, including equity arbitrage plays. Via InvestorPlace Performance More News Read More The 3 Biotech Stocks That Could Make Your February Unforgettable February 15, 2024 Via InvestorPlace AMBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAM February 10, 2024 From Kahn Swick & Foti, LLC Via Business Wire Looking Into Ambrx Biopharma's Recent Short Interest January 29, 2024 Via Benzinga Assessing Ambrx Biopharma: Insights From 7 Financial Analysts January 09, 2024 Via Benzinga Health Care Company Johnson & Johnson Announces Merger With Ambrx Biopharma January 08, 2024 Via Benzinga Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson January 27, 2024 Via The Motley Fool Johnson & Johnson Secures Complete FDA Approval For Bladder Cancer Drug Balversa, After Almost Five Years Of Accelerated Approval January 22, 2024 Via Benzinga Exposures Product Safety Johnson & Johnson's Q4 Earnings: Spotlight On Dividend Security Following Kenvue Split, Legal Costs, Acquisitions January 22, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP) January 16, 2024 From Brodsky & Smith LLC Via GlobeNewswire Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week January 13, 2024 Via Talk Markets Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review January 12, 2024 Via Investor's Business Daily Topics ETFs AMBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAM January 10, 2024 From Kahn Swick & Foti, LLC Via Business Wire Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030 January 09, 2024 Via FinancialNewsMedia BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP) January 08, 2024 From Brodsky & Smith LLC Via GlobeNewswire Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030 January 09, 2024 From FN Media Group LLC Via GlobeNewswire Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results January 08, 2024 Via Benzinga Topics Stocks Exposures US Equities Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 08, 2024 Via Benzinga Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher January 08, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today? January 08, 2024 Via InvestorPlace Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal January 08, 2024 Via Benzinga US Stocks Mixed; Nasdaq Jumps Over 100 Points January 08, 2024 Via Benzinga Topics Stocks Exposures US Equities J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value January 08, 2024 Via Investor's Business Daily Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.